Welcome to the website for the ACL SNNAP trial - Comparison of the clinical and cost effectiveness of two management strategies for non-acute Anterior Cruciate Ligament (ACL) injury: Rehabilitation versus surgical Reconstruction. The site is designed for both patients who are interested in participating in ACL SNNAP and clinicians and researchers who are involved in delivering the trial. ACL SNNAP is a multi-centre superiority randomised controlled trial, with internal recruitment pilot using a 2 arm parallel group design with 1:1 allocation ratio. We aim to recruit over 320 patients aged 18 years and over with symptomatic ACL deficiency confirmed by clinical assessment and MRI scan. The ACL SNNAP trial is funded by the National Institute for Health Research Health Technology Assessment Programme. We hope that you find the information you are looking for here on the website. If you have any questions or comments, please get in touch with the ACL SNNAP trial team using the contact details at the bottom of this page.
Chief Investigator: Professor David Beard
Trial Manager: Loretta Davies
SITU Portfolio Manager: Cushla Cooper
There are several locations throughout the country to this study.
Please access the involved staff page for more site specific information. There access and download site documents. forms, links, among others.
The ACL SNNAP Trial objective is to determine in patients with non-acute Anterior Cruciate Ligament Deficiency whether a non-surgical management (Rehabilitation, with later option for surgery if needed) is more effective than surgical management (Reconstruction).
If you have any questions relative to this study please refer to the FAQs or contact us.
